Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial

Table 1 Baseline data in the intervention and comparison arms

Variables	Intervention arm (n = 42)	Comparison arm (n = 42)	Comparison between groups (P-value)*
Age (y)	28 (26–30)	27 (24–28)	0.71
Weight (kg)	68.02 ± 11.28	70.47 ± 14.08	0.39
Body Mass Index (kg/m²)	25.93 ± 4.18	27.31 ± 4.78	0.16
Physical activity level (MET-min/week)	594 (198–1282.5)	462 (231–997.5)	0.5
Fasting blood sugar (mg/dl)	90.32 ± 7.52	89.19 ± 8.5	0.52
Serum level of vitamin K (ng/ml)	436.95 (400–495.7)	434.3 (401.2–492.02)	0.85
Depression status	16.9 ± 7.918	13.78 ± 9.05	0.1

*Parametric data were analyzed by independent samples t test, and non-parametric data were Mann–Whitney U test
P-values less than 0.05 were considered as the significant level of differences
Information is shown as mean ± SD or median (IQR)

ISSN: 1472-6874